137 related articles for article (PubMed ID: 6414186)
1. Improvement of plasma quality as raw material for factor VIII:C concentrates. Storage of whole blood and plasma and interindividual plasma levels of fibrinopeptide A.
Carlebjörk G; Blombäck M; Akerblom O
Vox Sang; 1983; 45(3):233-42. PubMed ID: 6414186
[TBL] [Abstract][Full Text] [Related]
2. FPA content - a criterion of quality for plasma as factor VIII source.
Pflugshaupt R; Kurt G
Vox Sang; 1983; 45(3):224-32. PubMed ID: 6414185
[TBL] [Abstract][Full Text] [Related]
3. Shelf-life of bank blood and stored plasma with special reference to coagulation factors.
Nilsson L; Hedner U; Nilsson IM; Robertson B
Transfusion; 1983; 23(5):377-81. PubMed ID: 6414128
[TBL] [Abstract][Full Text] [Related]
4. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
[TBL] [Abstract][Full Text] [Related]
5. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
Morfini M; Longo G; Matucci M; Vannini S; Messori A; Filimberti E; Duminuco M; Avanzi G; Rossi-Ferrini P
Ric Clin Lab; 1984; 14(4):681-91. PubMed ID: 6441235
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of factor VIII antigen by means of a simple slide test.
Casonato A; Fabris F; Vicariotto M; Girolami A
Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
[TBL] [Abstract][Full Text] [Related]
7. Stability of VIII:C in plasma: the dependence on protease activity and calcium.
Rock GA; Cruickshank WH; Tackaberry ES; Ganz PR; Palmer DS
Thromb Res; 1983 Mar; 29(5):521-35. PubMed ID: 6407138
[TBL] [Abstract][Full Text] [Related]
8. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
Hellings JA; Over J; van Mourik JA
Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
[TBL] [Abstract][Full Text] [Related]
9. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
10. Destruction of ristocetin cofactor by coagulation at 4 degrees C.
Lloyd JV; Tunbridge LJ; Rodgers SE; Hondow JA; Russell WJ
Thromb Res; 1985 Mar; 37(6):659-68. PubMed ID: 3922085
[TBL] [Abstract][Full Text] [Related]
11. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
12. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma.
Blombäck M; Chmielewska J; Netré C; Akerblom O
Vox Sang; 1984; 47(5):335-42. PubMed ID: 6209855
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII complex in myelomatosis and related disorders.
Leone G; Valori VM; Zini G; Bavaro P; Bartoloni C; Bizzi B
Ric Clin Lab; 1982; 12(4):581-8. PubMed ID: 6818670
[TBL] [Abstract][Full Text] [Related]
14. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein.
Mettinger KL
Thromb Res; 1982 Jul; 27(2):155-60. PubMed ID: 6814002
[TBL] [Abstract][Full Text] [Related]
15. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
Tran TH; Lämmle B; Duckert F
Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
[TBL] [Abstract][Full Text] [Related]
17. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
18. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays.
Hornsey VS; Waterston YG; Prowse CV
J Clin Pathol; 1988 May; 41(5):562-7. PubMed ID: 3133400
[TBL] [Abstract][Full Text] [Related]
19. Stability of von Willebrand factor in blood stored at 4 degrees C.
Hondow JA; Russell WJ; Tunbridge LJ; Lloyd JV
Thromb Res; 1982 Jul; 27(2):125-30. PubMed ID: 6814001
[No Abstract] [Full Text] [Related]
20. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
